Pharmaceutical Subscribe to Pharmaceutical
Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics, Distribution), Phases (I to IV), Type (Small molecule, Biologics, Medical Devices) Therapeutic Areas (Oncology, CNS, CVD, Infectious, Immunology) – Global Forecast 2026
“Increasing R&D expenditure of pharmaceutical and biopharmaceutical companies is driving the overall growth of the clinical trial supplies market”
The global clinical trial supplies market is projected to reach USD 2.9 billion by 2026...
Pharmaceutical Packaging Market by Raw Material (Plastics, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled syringes), Drug Delivery, and Region – Global Forecast to 2026
“The global pharmaceutical packaging market size is projected to reach USD 196.8 billion by 2026 from USD at a CAGR of 14.5% during the forecast period.”
The global pharmaceutical packaging market size is projected to reach USD 196.8 billion...
Coronavirus Disease 2019 (COVID-19) Vaccines – Opportunity Assessment and Forecast to 2026
Summary
The Coronavirus Disease 2019 (COVID-19) Vaccines – Opportunity Assessment and Forecast to 2026 gives a COVID-19 disease overview, epidemiology overview, current marketed vaccines, unmet needs, pipeline assessment, and market outlook.
GlobalData...
Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry – Implications and Outlook – 2021 Edition
Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry – Implications and Outlook – 2021 Edition
Summary
This report is the third edition of our analysis of mergers and acquisitions in the pharmaceutical...
Huntington’s Disease – Opportunity Assessment and Forecast to 2030
Huntington’s Disease – Opportunity Assessment and Forecast to 2030
Summary
Huntington’s disease (HD) is a rare, autosomal-dominant, neurodegenerative disorder, characterized by impaired motor control, cognitive dysfunction,...
Uveitis – Epidemiology Forecast to 2029
Uveitis – Epidemiology Forecast to 2029
Summary
Uveitis is a condition characterized by the inflammation of the uveal tract (iris, ciliary body, and choroid), but can also cause the inflammation of nearby tissues, such as the retina, the...
Pompe Disease – Opportunity Assessment and Forecast to 2030
Pompe Disease – Opportunity Assessment and Forecast to 2030
Summary
Pompe Disease (PD), also known as glycogen storage disease II, is a recessive genetic metabolic disorder caused by a deficiency in the enzyme ?-glucosidase (GAA). GAA...
Uveitis – Global Drug Forecast and Market Analysis to 2029
Uveitis – Global Drug Forecast and Market Analysis to 2029
Summary
Uveitis affecting the anterior chamber is typically treated with corticosteroid eye drops such as Allergan’s Pred Forte (prednisolone acetate) or Novartis’...
Fibromyalgia – Competitive Landscape in 2021
Fibromyalgia – Competitive Landscape in 2021
Summary
This reports provides a data-driven overview of the current and future competitive landscape in fibromyalgia therapeutics.
In fibromyalgia Cannabinoid receptor-1 is a major focus of...
Dyslipidemia – Competitive Landscape in 2021
Dyslipidemia – Competitive Landscape in 2021
Summary
This reports provides a data-driven overview of the current and future competitive landscape in dyslipidemia therapeutics.
In dyslipidemia 3 hydroxy 3 methylglutaryl coenzyme a (HMG...
